Discover why we’ve chosen to invest in this city and its people
Industry began on The Island Quarter in the 1800s when Nottingham’s early entrepreneurs set up in business. Flanked by canals and called ‘The Island,’ the area swiftly became home to lace-makers, cotton traders and drug companies. It was in the 1890s when the Boots Drug Co moved in, eventually occupying the whole site before leaving in 1996.
From the mid 1990s, former Boots warehousing was removed to make way for new buildings for the BBC, Premier Inn, Apex Court and the NHS Walk-in Centre, but the The Island Quarter has been largely derelict since then.
In 2016, Conygar purchased the site renaming it The Island Quarter and securing outline planning permission in 2019. The first phase will open in early 2022, with the final phase of development due to be complete by 2030.
Nottingham is a city with independence running through its veins. While its lace-making prowess was envied and copied across the world, Nottingham’s industrial and commercial heritage boasted two iconic British brands – Raleigh and Boots. It’s known throughout the world as the city where Ibruprofen and the MRI Scanner were invented. Nottingham also gave the world the traffic lights system.
This sort of innovation is led by Nottingham’s two globally renowned universities and its cutting-edge biosciences sector, alongside a local authority with aspirations to ensure this Core City maintains its rightful place as an international player.
From the writers of old such as D H Lawrence and Byron, to modern day stars such as global fashion designer Paul Smith and cult film director Shane Meadows, we are proud to be investing in a city with so much talent and potential.